These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 7906821

  • 1. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin.
    Ramage JK, Hale A, Gane E, Cohen B, Boyle M, Mufti G, Williams R.
    Lancet; 1994 Mar 12; 343(8898):667-8. PubMed ID: 7906821
    [No Abstract] [Full Text] [Related]

  • 2. Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection.
    Rivas-Delgado A, Matutes E, Rozman M.
    Br J Haematol; 2016 Feb 12; 172(4):495. PubMed ID: 26457576
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful re-transplantation in patient with recurrent parvovirus B19 pure red cell aplasia.
    Inamdar N, Nada R, Minz R, Kenwar DB, Singh S, Sharma A, Kumar V, Rathi M, Kohli HS, Ramachandran R.
    Transpl Infect Dis; 2019 Dec 12; 21(6):e13164. PubMed ID: 31483919
    [Abstract] [Full Text] [Related]

  • 6. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM, Flynn JT, Schechner RS, Pullman JM, Feuerstein D, Del Rio M.
    Pediatr Transplant; 2005 Dec 12; 9(6):801-4. PubMed ID: 16269055
    [Abstract] [Full Text] [Related]

  • 7. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
    Tavil B, Sanal O, Turul T, Yel L, Gurgey A, Gumruk F.
    Pediatr Hematol Oncol; 2009 Mar 12; 26(2):63-8. PubMed ID: 19322736
    [Abstract] [Full Text] [Related]

  • 8. Parvovirus B19-related anemia in HIV-infected patients.
    Koduri PR.
    AIDS Patient Care STDS; 2000 Jan 12; 14(1):7-11. PubMed ID: 12240888
    [Abstract] [Full Text] [Related]

  • 9. Persistent parvovirus B19 infection resulting in red cell aplasia after allogeneic hematopoietic stem cell transplantation.
    Koda Y, Mori T, Kato J, Kohashi S, Kikuchi T, Mitsuhashi T, Murata M, Uemura T, Handa M, Okamoto S.
    Transpl Infect Dis; 2013 Dec 12; 15(6):E239-42. PubMed ID: 24134728
    [Abstract] [Full Text] [Related]

  • 10. Parvovirus B19-induced red blood cell aplasia complicating iron-deficiency anemia.
    Tarantino MD, Shahidi NT.
    Clin Pediatr (Phila); 1995 Feb 12; 34(2):108-9. PubMed ID: 7729105
    [No Abstract] [Full Text] [Related]

  • 11. Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys.
    Corral DA, Darras FS, Jensen CW, Hakala TR, Naides SJ, Krause JR, Starzl TE, Jordan ML.
    Transplantation; 1993 Feb 12; 55(2):427-30. PubMed ID: 8434395
    [No Abstract] [Full Text] [Related]

  • 12. Red cell aplasia caused by parvovirus B19 in AIDS: use of i.v. immunoglobulin.
    Koduri PR, Kumapley R, Khokha ND, Patel AR.
    Ann Hematol; 1997 Feb 12; 75(1-2):67-8. PubMed ID: 9322687
    [Abstract] [Full Text] [Related]

  • 13. [Erythroid aplasia caused by parvovirus B19 in congenital dyserythropoietic anemia].
    Martín MV, García-Tapia AM, Fernández C, Muñoz JA.
    Sangre (Barc); 1993 Oct 12; 38(5):416-7. PubMed ID: 8140511
    [No Abstract] [Full Text] [Related]

  • 14. Successful Treatment of Anemia With Anaplastic and Microangiopathic Characteristics in a Kidney Transplant Recipient With Parvovirus B19 Infection: A Case Report.
    Mascia G, Argiolas D, Carta E, Ibba S, Piredda GB.
    Transplant Proc; 2020 Jun 12; 52(5):1619-1622. PubMed ID: 32389489
    [Abstract] [Full Text] [Related]

  • 15. Pure red cell aplasia, peripheral thrombocytopenic purpura, and parvovirus B19 infection in a women seropositive for human immunodeficiency virus.
    Blanche P, Wyplosz B, Herry I, Salmon D, Sicard D.
    Clin Infect Dis; 1994 Jul 12; 19(1):215. PubMed ID: 7948543
    [No Abstract] [Full Text] [Related]

  • 16. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia.
    Gahr M, Pekrun A, Eiffert H.
    Eur J Pediatr; 1991 May 12; 150(7):470-2. PubMed ID: 1915497
    [Abstract] [Full Text] [Related]

  • 17. Pure red blood cell aplasia associated with parvovirus B19 infection in large granular lymphocyte leukemia.
    Ergas D, Resnitzky P, Berrebi A.
    Blood; 1996 Apr 15; 87(8):3523-4. PubMed ID: 8605376
    [No Abstract] [Full Text] [Related]

  • 18. Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia.
    Mouthon L, Michel M, Gandré C, Montagnier-Petrissans C, Chevreul K.
    Clin Infect Dis; 2015 Feb 01; 60(3):488. PubMed ID: 25336624
    [No Abstract] [Full Text] [Related]

  • 19. Persistent parvovirus B19 infection and pure red cell aplasia in Waldenström's macroglobulinemia: successful treatment with high-dose intravenous immunoglobulin.
    Karmochkine M, Oksenhendler E, Leruez-Ville M, Jaccard A, Morinet F, Herson S.
    Am J Hematol; 1995 Nov 01; 50(3):227-8. PubMed ID: 7485092
    [No Abstract] [Full Text] [Related]

  • 20. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient.
    Sturm I, Watschinger B, Geissler K, Guber SE, Popow-Kraupp T, Horl WH, Pohanka E.
    Nephrol Dial Transplant; 1996 Jul 01; 11(7):1367-70. PubMed ID: 8672044
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.